Search results for

The former senior adviser to President Obama suggested the Democratic presidential nominee should work with, not against, the press in an effort to be more transparent.

The aim is to make clinical trial data available to volunteers and scientists, even if a drug or therapy being tested turns out to be a failure. That could help identify serious side effects.

The Hillary Victory Fund raises major contributions and distributes the cash to Democratic organizations up and down the line. We follow the money from George Soros to field canvassers in Virginia.

Drug resistance is no longer a matter of health. It could have massive implications for the world's economy and food supply.

CEO John Stumpf apologized for betraying customers' trust in a hearing by the Senate Banking Committee to answer questions about Wells Fargo employees opening unauthorized customer accounts.

Sutherland plays a Cabinet member who becomes president after an explosion takes out the U.S. Capitol — and everyone above him in the pecking order. Critic John Powers has a review.

NPR's Scott Simon and Tom Goldman discuss the Cubs and the curse, the Paralympic games in Rio, and one wheelchair racer who is stirring up a discussion about euthanasia.

The alliance's most recent challenges involve the war in Syria and containing the refugee crisis. David Greene talks to NATO Secretary General Jens Stoltenberg about Syria and the future of the NATO.

David Greene talks to Espin Egil Hansen, a newspaper editor in Norway, who says Facebook needs to admit it is a powerful editor, and has to take more responsibility for its editorial decisions.

Edward Snowden is having a big week, as the subject of both a laudatory new Oliver Stone biopic and a scathing report from the House Intelligence Committee. We examine the competing narratives.